LV12045A - N-monoaizvietotu un N,N'-divaizvietotu nesimetrisku ciklisku urinvielas atvasinajumu iegusanas panemiens - Google Patents

N-monoaizvietotu un N,N'-divaizvietotu nesimetrisku ciklisku urinvielas atvasinajumu iegusanas panemiens

Info

Publication number
LV12045A
LV12045A LV970248A LV970248A LV12045A LV 12045 A LV12045 A LV 12045A LV 970248 A LV970248 A LV 970248A LV 970248 A LV970248 A LV 970248A LV 12045 A LV12045 A LV 12045A
Authority
LV
Latvia
Prior art keywords
doubly
satisfaction
mono
acquisition
substituted
Prior art date
Application number
LV970248A
Other languages
English (en)
Other versions
LV12045B (lv
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of LV12045A publication Critical patent/LV12045A/lv
Publication of LV12045B publication Critical patent/LV12045B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-97-248A 1995-06-07 1998-01-28 N-monoaizvietotu un n,n'-divaizvietotu nesimetrisku ciklisku urīnvielas atvasinājumu iegūšanas paņēmiens LV12045B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
PCT/US1996/009021 WO1996040652A1 (en) 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas

Publications (2)

Publication Number Publication Date
LV12045A true LV12045A (lv) 1998-05-20
LV12045B LV12045B (lv) 1998-09-20

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-248A LV12045B (lv) 1995-06-07 1998-01-28 N-monoaizvietotu un n,n'-divaizvietotu nesimetrisku ciklisku urīnvielas atvasinājumu iegūšanas paņēmiens

Country Status (26)

Country Link
US (1) US5532357A (lv)
EP (2) EP1029859A1 (lv)
JP (1) JPH11506779A (lv)
KR (1) KR19990022467A (lv)
CN (1) CN1192209A (lv)
AR (1) AR002384A1 (lv)
AU (1) AU704535B2 (lv)
BR (1) BR9609493A (lv)
CA (1) CA2223391A1 (lv)
CZ (1) CZ381997A3 (lv)
EA (1) EA000363B1 (lv)
EE (1) EE9700330A (lv)
HR (1) HRP960259A2 (lv)
HU (1) HUP9900913A2 (lv)
IL (1) IL122424A0 (lv)
LT (1) LT4381B (lv)
LV (1) LV12045B (lv)
MX (1) MX9709652A (lv)
NO (1) NO975679L (lv)
NZ (1) NZ309648A (lv)
PL (1) PL323993A1 (lv)
SI (1) SI9620077A (lv)
SK (1) SK164397A3 (lv)
TW (1) TW358091B (lv)
WO (1) WO1996040652A1 (lv)
ZA (1) ZA964847B (lv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
JP2001503428A (ja) * 1996-11-08 2001-03-13 デュポン ファーマシューティカルズ カンパニー Ｈｉｖプロテアーゼ阻害剤として有効な１―（３―アミノインダゾール―５―イル）―３―フィニルメチル―環式尿素類
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
EP0973767A1 (en) * 1997-03-31 2000-01-26 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) * 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
EP1091944A1 (en) * 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
EP1183242A2 (en) 1999-05-26 2002-03-06 Du Pont Pharmaceuticals Company 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
WO2002078628A2 (en) * 2001-03-28 2002-10-10 Bristol-Myers Squibb Company Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
BR9206623A (pt) * 1991-10-11 1995-05-02 Du Pont Merck Pharma Uréias cíclicas e análogas úteis como inibidoras da protease retroviral
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
NZ309648A (en) 1998-09-24
NO975679L (no) 1998-02-02
HRP960259A2 (en) 1997-10-31
EA199800034A1 (ru) 1998-08-27
CA2223391A1 (en) 1996-12-19
EA000363B1 (ru) 1999-06-24
EP0837855A1 (en) 1998-04-29
AU704535B2 (en) 1999-04-29
LV12045B (lv) 1998-09-20
HUP9900913A2 (hu) 1999-09-28
US5532357A (en) 1996-07-02
EE9700330A (et) 1998-06-15
CZ381997A3 (cs) 1999-01-13
CN1192209A (zh) 1998-09-02
JPH11506779A (ja) 1999-06-15
LT97188A (en) 1998-04-27
WO1996040652A1 (en) 1996-12-19
BR9609493A (pt) 1999-03-02
LT4381B (lt) 1998-09-25
EP0837855A4 (en) 1998-09-02
AR002384A1 (es) 1998-03-11
SK164397A3 (en) 2000-04-10
SI9620077A (sl) 1998-08-31
NO975679D0 (no) 1997-12-05
IL122424A0 (en) 1998-06-15
AU5986896A (en) 1996-12-30
MX9709652A (es) 1998-03-29
ZA964847B (en) 1997-12-08
TW358091B (en) 1999-05-11
PL323993A1 (en) 1998-04-27
KR19990022467A (ko) 1999-03-25
EP1029859A1 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
DE69532495D1 (de) Oxazolidindion-Derivate, ihre Herstellung und Verwendung
FR2744442B1 (fr) Preparation du 1,1,1,3,3-pentachlorobutane et du 1,1,1,3,3,-pentafluorobutane
DE59010247D1 (de) Neue Polythiophen-Dispersionen, ihre Herstellung und ihre Verwendung
FI970704L (fi) Miesten inkontinenssilaite
EP1012266A4 (en) GALECTIN 8, 9, 10 AND 10SV.
FR2717697B1 (fr) Instrument d'implantation.
FI914487A7 (fi) 1,3-bentsoksatsiinijohdannaiset, niiden valmistus ja käyttö
LV12045A (lv) N-monoaizvietotu un N,N'-divaizvietotu nesimetrisku ciklisku urinvielas atvasinajumu iegusanas panemiens
FI910300A7 (fi) Uusia 1,3-dikarbonyyliyhdisteitä ja niiden käyttö
FR2712801B1 (fr) Structure absorbante et vêtement l'incorporant.
DK0821692T3 (da) Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf
DE69213183D1 (de) N'-Cyanomethylethylendiamin-N,N'-Diessigsäure, ihre Salze und ihre Herstellung
FI923458A7 (fi) 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
DE59108809D1 (de) 3-(Cis-3-Hexenyloxy)-propan-nitrile, dessen Herstellung und dessen Verwendung
DE69011356D1 (de) 6'Deoxy-6'-halogenoneplanosin A und dessen Herstellung.
FR2716157B1 (fr) Agencement d'ancrage.
HUP0000179A3 (en) 1,3-oxazin-4-one derivatives as herbicides, preparation and use thereof
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
FI973631A7 (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
ITTO940810A0 (it) "sedia"
BR7603083U (pt) "Não durma"
IT1284060B1 (it) Dispositivo per l'introduzione in stie e simili di avicoli in genere e di tacchini in particolare
KR930017816U (ko) 유희용 다리